ResearcherCentre Hospitalier Universitaire VaudoisNo recent work listed
Markus Schäfer
Matched on ORCID iD 0000-0003-4335-4098; OpenAlex author ID A5056887495. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 5
- Reply to: Deep insight into lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2022.06.026↗
- Prognostic role of splenic vessel infiltration in distal pancreatic adenocarcinoma: Comment on: Systematic review and meta-analysis of prognostic role of splen… Last author DOI 10.1016/j.ejso.2018.02.013↗
- Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome? Last author DOI 10.1097/meg.0000000000001266↗
- Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body Radiation Therapy" [Critical Reviews in O… Co-author DOI 10.1016/j.critrevonc.2016.12.010↗
- Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy. Co-author DOI 10.1016/j.critrevonc.2016.05.003↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nicolas Demartines · 3 shared papers, 2018–2022 · strength 0.45
- Paper Reply to: Deep insight into lymph node metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejso.2022.06.026↗
- Paper Prognostic role of splenic vessel infiltration in distal pancreatic adenocarcinoma: Comment on: Systematic review and m… DOI 10.1016/j.ejso.2018.02.013↗
- Paper Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome? DOI 10.1097/meg.0000000000001266↗
- Gaëtan‐Romain Joliat · 2 shared papers, 2018–2022 · strength 0.36
- Michael H. Schneider · 1 shared paper, 2022 · strength 0.22
- Rosario Mazzola · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
- Filippo Alongi · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
- Berardino De Bari · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
- Mahmut Özşahin · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
- David Petermann · 1 shared paper, 2018 · strength 0.09
- Nermin Halkic · 1 shared paper, 2018 · strength 0.09
- David J. Martin · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.